February 15, 2011

Dear Sir or Madam:

As you may know, gout is a painful form of arthritis that primarily affects seniors. Patients afflicted with this disease depend on colchicine products to treat acute gout flare-ups that often occur at varying frequencies and intensities depending on individual patients.

by James L. Martin

More than 17,000 women with late-stage breast cancer rely on a drug called Avastin to extend and save their lives.  But the drug may be taken away as a treatment option for most doctors and patients if the Food and Drug Administration (FDA) has its way.  Such a decision would bankrupt families, create a two-tier health care system in the United States, and literally kill women and seniors who are denied access to the drug.  The stakes could not be higher.

Dear Mr. Martin:

Thank you for your letter of November 15, 2010.  I appreciate the opportunity to respond to your question concerning the duration of our Colcrys Patient Assistances Program (PAP) and to offer additional information about this initiative.

November 15, 2010

Richard H. Roberts, M.D., Ph.D.
URL Pharma
1100 Orthodox Street
Philadelphia, PA 19124

Dear Mr. Roberts,

I am writing to you to discuss Colcrys, URL Pharma’s FDA-approved colchicine product.

60 Plus applauds FDA’s removal of untested colchicine from market, but reminds that more work is needed to protect patient safety

ALEXANDRIA, Va.–(BUSINESS WIRE)–James L. Martin, chairman of the 60 Plus Association, a seniors advocacy group, applauded the Food and Drug Administration’s (FDA) decision to remove unapproved colchicine products from the market, and called on drug manufacturers, distributors and pharmacies to help the FDA protect patients from unapproved drugs.

60 Plus salutes, Florida Senate candidate, Marco Rubio.   Earlier this summer, 60 Plus Association’s Chairman, Jim Martin and 60 Plus’ spokesperson, Pat Boone announced that Rubio won the organization’s Honorary Guardian of Seniors’ Rights award.

By Jim Martin – The Daily Caller

Seniors depend largely on the medical expertise provided to them by their physicians. We have little choice but to trust that they are helping us make good health decisions, and most importantly, putting safety first.